| scholarly article | Q13442814 |
| P50 | author | Sylvie Miquel | Q85069522 |
| P2093 | author name string | Bertrand Souweine | |
| Christiane Forestier | |||
| Rosyne Lagrafeuille | |||
| P2860 | cites work | Biofilms: survival mechanisms of clinically relevant microorganisms | Q22299328 |
| Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults | Q24202113 | ||
| Enzymatic detachment of Staphylococcus epidermidis biofilms | Q24564021 | ||
| Antimicrobial peptides as potential tool to fight bacterial biofilm | Q39201598 | ||
| Screening of probiotic lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. | Q39281079 | ||
| Arrested protein synthesis increases persister-like cell formation. | Q39298780 | ||
| Staphylococcus epidermidis Esp Degrades Specific Proteins Associated with Staphylococcus aureus Biofilm Formation and Host-Pathogen Interaction | Q39798710 | ||
| A new biofilm-associated colicin with increased efficiency against biofilm bacteria. | Q39853603 | ||
| Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. | Q39902511 | ||
| A combination of cis-2-decenoic acid and antibiotics eradicates pre-established catheter-associated biofilms | Q40211808 | ||
| The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | Q40231712 | ||
| Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. | Q40295968 | ||
| Particle-based multidimensional multispecies biofilm model | Q40512396 | ||
| Trigonella foenum-graceum (Seed) Extract Interferes with Quorum Sensing Regulated Traits and Biofilm Formation in the Strains of Pseudomonas aeruginosa and Aeromonas hydrophila | Q40524045 | ||
| Photoactive TiO₂ antibacterial coating on surgical external fixation pins for clinical application | Q40567908 | ||
| Effects of Baseplates of Orthodontic Appliances with in situ generated Silver Nanoparticles on Cariogenic Bacteria: A Randomized, Double-blind Cross-over Clinical Trial | Q40843086 | ||
| Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly | Q40978358 | ||
| Effects of antibiotics on biofilm and unattached cells of a clinical Staphylococcus aureus isolate from bone and joint infection. | Q41039011 | ||
| Sonorensin: A new bacteriocin with potential of an anti-biofilm agent and a food biopreservative | Q41041363 | ||
| Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Tri | Q41096700 | ||
| Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial. | Q41124289 | ||
| Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial | Q41492109 | ||
| Non-toxic plant metabolites regulate Staphylococcus viability and biofilm formation: a natural therapeutic strategy useful in the treatment and prevention of skin infections | Q41662033 | ||
| Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms | Q41771325 | ||
| In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli | Q41807252 | ||
| Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm | Q41876061 | ||
| Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion | Q42020273 | ||
| Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm | Q42110066 | ||
| Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials | Q42200374 | ||
| Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection. | Q42876968 | ||
| Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm | Q42933742 | ||
| Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization | Q42937090 | ||
| Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. | Q42975780 | ||
| Photodynamic therapy: a new antimicrobial approach to infectious disease? | Q24626076 | ||
| A fatty acid messenger is responsible for inducing dispersion in microbial biofilms | Q24647900 | ||
| Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells | Q24682375 | ||
| Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria | Q26786947 | ||
| Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis | Q26830457 | ||
| A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe | Q27000702 | ||
| Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
| The biogeography of polymicrobial infection | Q28070102 | ||
| Alternative antimicrobial approach: nano-antimicrobial materials | Q28081490 | ||
| Antibiotic lock therapy: review of technique and logistical challenges | Q28082777 | ||
| Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Q28241661 | ||
| Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization | Q28282944 | ||
| Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial | Q28291322 | ||
| Antibiofilm activity of Actinobacillus pleuropneumoniae serotype 5 capsular polysaccharide | Q28487976 | ||
| Anti-biofilm activity: a function of Klebsiella pneumoniae capsular polysaccharide | Q28539739 | ||
| Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. | Q30403958 | ||
| The role of metagenomics in understanding the human microbiome in health and disease | Q31148228 | ||
| A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trial* | Q33393487 | ||
| The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review | Q33396442 | ||
| Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). | Q33414914 | ||
| Atmospheric pressure nonthermal plasmas for bacterial biofilm prevention and eradication | Q33464780 | ||
| Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli | Q33534627 | ||
| Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial | Q33592960 | ||
| Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis | Q33623289 | ||
| Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America | Q33688646 | ||
| Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis. | Q33794543 | ||
| iDynoMiCS: next-generation individual-based modelling of biofilms | Q33848394 | ||
| Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. | Q33876518 | ||
| The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. | Q33999490 | ||
| Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial | Q43198685 | ||
| In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea | Q43474835 | ||
| Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock | Q43856628 | ||
| Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study | Q44077390 | ||
| Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock | Q44210656 | ||
| Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis | Q44374380 | ||
| Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial | Q44996354 | ||
| A Comparison of Effects of Broad-Spectrum Antibiotics and Biosurfactants on Established Bacterial Biofilms | Q45126340 | ||
| A streptococcal effector protein that inhibits Porphyromonas gingivalis biofilm development. | Q45965114 | ||
| A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. | Q46487210 | ||
| Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial | Q46616429 | ||
| Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial | Q46640174 | ||
| Mechanisms of Competition in Biofilm Communities | Q46699287 | ||
| Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation | Q46874947 | ||
| Promising results of cranberry in the prevention of oral Candida biofilms. | Q46920068 | ||
| Surfactin reduces the adhesion of food-borne pathogenic bacteria to solid surfaces. | Q50054839 | ||
| In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms | Q50259988 | ||
| Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. | Q51056890 | ||
| Bactericidal activity of ceftaroline against mature Staphylococcus aureus biofilms | Q51062388 | ||
| Protozoan grazing and its impact upon population dynamics in biofilm communities | Q51564246 | ||
| Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience | Q51744609 | ||
| Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. | Q54083013 | ||
| Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study | Q54338318 | ||
| The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway | Q54434727 | ||
| Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial. | Q55065080 | ||
| Influence of cranberry juice on attachment of Escherichia coli to glass | Q62183896 | ||
| Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients | Q71787299 | ||
| Inhibition of Staphylococcus aureus adherence to Caco-2 cells by lactobacilli and cell surface properties that influence attachment | Q84869363 | ||
| In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata | Q85264666 | ||
| Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria | Q87133045 | ||
| Microbiological methods for target-oriented screening of biofilm inhibitors | Q87512780 | ||
| A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms | Q34057449 | ||
| Protozoan Bacterivory and Escherichia coli Survival in Drinking Water Distribution Systems | Q34070945 | ||
| Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus. | Q34072903 | ||
| A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis | Q34102464 | ||
| Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates | Q34123800 | ||
| Oral-derived bacterial flora defends its domain by recognizing and killing intruders--a molecular analysis using Escherichia coli as a model intestinal bacterium | Q34195537 | ||
| Catheter-associated infections: pathogenesis affects prevention | Q34237921 | ||
| Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing | Q34252814 | ||
| Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus | Q34291700 | ||
| Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution | Q34302325 | ||
| Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin | Q34328275 | ||
| A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials | Q34432187 | ||
| Pseudomonas aeruginosa rhamnolipids disperse Bordetella bronchiseptica biofilms. | Q34442706 | ||
| A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial. | Q34465850 | ||
| Contribution of Lactococcus lactis reducing properties to the downregulation of a major virulence regulator in Staphylococcus aureus, the agr system | Q34594155 | ||
| Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates. | Q34596619 | ||
| Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin | Q34597842 | ||
| Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic | Q34650340 | ||
| Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent | Q34732850 | ||
| Medical biofilms | Q34764576 | ||
| Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials | Q35017412 | ||
| Staphylococcus aureusBiofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In Vivo | Q35033196 | ||
| Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide | Q35033785 | ||
| Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis | Q35040693 | ||
| Antiplaque effect of essential oils and 0.2% chlorhexidine on an in situ model of oral biofilm growth: a randomised clinical trial. | Q35091540 | ||
| Gut ecosystem: how microbes help us. | Q35105266 | ||
| Phage-mediated dispersal of biofilm and distribution of bacterial virulence genes is induced by quorum sensing | Q35113072 | ||
| Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial | Q35133595 | ||
| The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans | Q35164607 | ||
| Unsaturated fatty acid, cis-2-decenoic acid, in combination with disinfectants or antibiotics removes pre-established biofilms formed by food-related bacteria. | Q35202362 | ||
| Probiotics to counteract biofilm-associated infections: promising and conflicting data | Q35278680 | ||
| In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon | Q35761748 | ||
| Campylobacter jejuni biofilms contain extracellular DNA and are sensitive to DNase I treatment | Q35837269 | ||
| Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms. | Q35901841 | ||
| In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection | Q35941284 | ||
| Photodynamic and Antibiotic Therapy in Combination to Fight Biofilms and Resistant Surface Bacterial Infections. | Q36183971 | ||
| Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells | Q36517851 | ||
| Bacterial biofilms within the clinical setting: what healthcare professionals should know | Q36625731 | ||
| Microbial biofilms in the human gastrointestinal tract | Q36797293 | ||
| Phage therapy: Should bacterial resistance to phages be a concern, even in the long run? | Q36958616 | ||
| Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells | Q37083889 | ||
| In Vitro Efficacies and Resistance Profiles of Rifampin-Based Combination Regimens for Biofilm-Embedded Methicillin-Resistant Staphylococcus aureus | Q37263546 | ||
| Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis | Q37333049 | ||
| A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients | Q37360314 | ||
| Evolving concepts in biofilm infections | Q37449114 | ||
| The social structure of microbial community involved in colonization resistance | Q37595150 | ||
| Therapeutic potential of biofilm-dispersing enzymes. | Q37620257 | ||
| Anti-virulence strategies to combat bacteria-mediated disease | Q37676924 | ||
| Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis | Q37773601 | ||
| New Challenges in the Diagnosis, Management, and Prevention of Central Venous Catheter-Related Infections | Q37867052 | ||
| Biofilms in drinking water and their role as reservoir for pathogens | Q37893315 | ||
| Multi-species biofilms: how to avoid unfriendly neighbors. | Q37978400 | ||
| Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters | Q38028826 | ||
| Recent patents on bacteriocins: food and biomedical applications. | Q38037799 | ||
| Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation | Q38134441 | ||
| Adverse effects associated with ethanol catheter lock solutions: a systematic review | Q38217203 | ||
| Quorum sensing inhibitors as anti-biofilm agents | Q38246176 | ||
| Biofilms, medical devices, and antibiofilm technology: key messages from a recent public workshop. | Q38275320 | ||
| Nonthermal plasma--A tool for decontamination and disinfection | Q38321342 | ||
| Induction of MRSA Biofilm by Low-Dose β-Lactam Antibiotics: Specificity, Prevalence and Dose-Response Effects | Q38370309 | ||
| Medical biofilms--nanotechnology approaches. | Q38493367 | ||
| The biofilm mode of life boosts the anti-inflammatory properties of Lactobacillus | Q38972681 | ||
| In vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar Enteritidis | Q39152864 | ||
| Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study | Q39200312 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biofilm | Q467410 |
| P304 | page(s) | 592 | |
| P577 | publication date | 2016-04-26 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Anti-biofilm Activity as a Health Issue | |
| P478 | volume | 7 |
| Q39406706 | Autotransporter adhesins in Escherichia coli pathogenesis. |
| Q40076742 | Bactericidal and Anti-biofilm Effects of Polyhexamethylene Biguanide in Models of Intracellular and Biofilm of Staphylococcus aureus Isolated from Bovine Mastitis. |
| Q39250412 | Biofilm dispersal: multiple elaborate strategies for dissemination of bacteria with unique properties |
| Q100761867 | Biofilm dynamics: linking in situ biofilm biomass and metabolic activity measurements in real-time under continuous flow conditions |
| Q44516863 | Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm |
| Q48261289 | Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition. |
| Q38974558 | Designing metallodrugs with nuclease and protease activity. |
| Q30359390 | Direct measurement of interaction forces between bovine serum albumin and poly(ethylene oxide) in water and electrolyte solutions |
| Q61450387 | Erubescensoic Acid, a New Polyketide and a Xanthonopyrone SPF-3059-26 from the Culture of the Marine Sponge-Associated Fungus KUFA 0220 and Antibacterial Activity Evaluation of Some of Its Constituents |
| Q92328520 | Flow Cytometry to Assess the Counts and Physiological State of Cronobacter sakazakii Cells after Heat Exposure |
| Q46358598 | Himatanthus drasticus Leaves: Chemical Characterization and Evaluation of Their Antimicrobial, Antibiofilm, Antiproliferative Activities. |
| Q40184318 | Lysinibacillus fusiformis M5 induces increased complexity in Bacillus subtilis 168 colony biofilms via hypoxanthine |
| Q37644095 | Marine Sponge-Derived Streptomyces sp. SBT343 Extract Inhibits Staphylococcal Biofilm Formation |
| Q89835058 | Plant Phenolics and Phenolic-Enriched Extracts as Antimicrobial Agents against Food-Contaminating Microorganisms |
| Q91963479 | Prevention of Pseudomonas aeruginosa Biofilm Formation on Soft Contact Lenses by Allium sativum Fermented Extract (BGE) and Cannabinol Oil Extract (CBD) |
| Q92578817 | Prevention of biofilm formation by quorum quenching |
| Q55006377 | Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP. |
| Q57110710 | Promising Antibiofilm Activity of Peptidomimetics |
| Q98243735 | Prophage phiv205-1 facilitates biofilm formation and pathogenicity of avian pathogenic Escherichia coli strain DE205B |
| Q98195430 | Pseudonajide peptide derived from snake venom alters cell envelope integrity interfering on biofilm formation in Staphylococcus epidermidis |
| Q41537426 | Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins. |
| Q58691429 | Structural Characterization of the FlmC Protein Involved in Biofilm Formation |
| Q33745974 | Synergistic antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms |
| Q61798033 | Synthesis and Evaluation of a Chitosan Oligosaccharide-Streptomycin Conjugate against Biofilms |
| Q92422461 | Testing Anti-Biofilm Polymeric Surfaces: Where to Start? |
| Q59942790 | α-Chymotrypsin Immobilized on a Low-Density Polyethylene Surface Successfully Weakens Escherichia coli Biofilm Formation |
Search more.